Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 1,837-1,848 of 1,909
Other study type icon
CompletedNCT00001170

the Psychological Development of Children of Parents With and Without Affective Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionObservationalA study where researchers collect information without assigning a treatment.
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity, Depression
Other study type icon
CompletedNCT00184418

The Immune System and Psychiatric Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Trondheim
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, Depression, ...Observational
Countries
Norway
Sponsor
Norwegian University of Science and Technology
Condition
Schizophrenia, Depression, ...
Other study type icon
CompletedNCT00029640

The Treatment of Children and Adolescents With Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityObservational
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression, Bipolarity
Behavioral study icon
Not recruitingISRCTN51629746

Early Youth Engagement in First Episode Psychosis (EYE-2) Controlled study

This study is not recruiting in the United Kingdom. It focuses on Schizophrenia.

In United Kingdom
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityOtherFrom 12 Years to 35 Years
Countries
United Kingdom
Sponsor
Sussex Partnership NHS Foundation Trust
Condition
Schizophrenia, Bipolarity
Behavioral study icon
Not recruitingISRCTN14689382

Ketamine-ECT Study

This study is looking at a support or therapy approach for people with Bipolarity, depression, Mental and Behavioural Disorders, or Bipolarity, current episode mild or moderate depression. Participants take part in the program or support approach and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
Manchester Mental Health & Social Care Trust (UK)
Condition
Bipolarity, Depression
Other study type icon
Not recruitingISRCTN54234300

ThrIVe-B feasibility study

This study is looking at whether a digital support tool can help people with Frequent mood swings within the context of a Bipolar Spectrum Disorder or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityOtherOver 18 Years
Countries
United Kingdom
Sponsor
Devon Partnership NHS Trust
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2004-003826-92

"A Randomized, Parallel Group, Open Trial Examining the Safety, Efficacy and Tolerability of Fast Titration, 800mg/day by day 4, of Quetiapine Fumarate Compared to Standard Titration, 400mg/day by ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Spain
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrugA study involving a medication or substance.
Countries
Spain
Sponsor
AstraZeneca Farmacéutica Spain, S.A.
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2018-001963-22

A multicentre, double-blind, randomised, placebo - controlled phase II study to assess efficacy, safety and pharmacokinetics of inhaled Esketamine in subject with treatment-resistant depression in ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Poland
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrug
Countries
Poland
Sponsor
Celon Pharma SA
Condition
Depression, Bipolarity
Drug study icon
TerminatedEUCTR 2004-003927-11

A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Continuing Lithium or ValproicAcid/Divalproex Sodium for the Treatment of...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrug
Countries
Czechia
Sponsor
NV Organon
Condition
Bipolarity
Drug study icon
TerminatedEUCTR 2012-004132-33

A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder with Mixed Features (Protocol No D1050304)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrug
Countries
United Kingdom
Sponsor
Sunovion Pharmaceuticals Inc.
Condition
Depression, Bipolarity
Drug study icon
TerminatedEUCTR 2012-001357-10

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) 0.1 mg a...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrug
Countries
United Kingdom, Bulgaria, Czechia, ...
Sponsor
Takeda Global Research & Development Centre (Europe) Ltd (TGRD)
Condition
Depression, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.